Navigation Links
Optimer Pharmaceuticals, Inc. Announces Presentation at ECCMID of Post-Hoc Subgroup Analysis of DIFICID in Adult Cancer Patients Being Treated for Clostridium difficile-Associated Diarrhea (CDAD)
Date:3/30/2012

SAN DIEGO, March 30, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced the presentation of results from a post-hoc subgroup analysis of the company's two large Phase 3 trials which demonstrated that cancer patients with Clostridium difficile-associated diarrhea (CDAD) had higher clinical cure rates, better sustained response and lower recurrence when treated with DIFICID® (fidaxomicin) tablets compared to oral vancomycin. The data will be presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in London.

(Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

The analysis included 153 patients with active cancer who were treated in the two DIFICID Phase 3 studies and who received 8 days or more of treatment with DIFICID or oral vancomycin. In the overall combined population, patients with cancer had significantly lower cure and sustained response rates than patients without cancer. DIFICID was five times more likely than vancomycin to produce a clinical response and three times more likely to lead to a sustained response, while patients treated with vancomycin had a 2.6 fold greater risk of experiencing recurrence. Specifically, DIFICID provided superior response compared to vancomycin across all clinical endpoints studied: clinical response (97.3% vs. 87.5%, 95% CI 1.07-23.98; p=0.041), sustained response (83.6% vs. 61.3%, 95% CI 1.50-6.91; p=0.003) and disease recurrence (14.1% vs. 30.0%, 95% CI 0.16-0.89; p=0.025). Furthermore, cancer patients who were treated with DIFICID in the clinical studies had similar cure, recurrence and sustained response rates as non-cancer patients who received the drug, while cancer patients treated with vancomycin tended to have poorer outcomes than non-cancer patients. The ov
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Optimer Reports Fourth Quarter and Fiscal Year 2011 Financial Results
2. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and FY 2011 Financial Results
3. Optimer Pharmaceuticals to Present at the 32nd Annual Cowen Health Care Conference
4. Optimer Pharmaceuticals Provides Update on DIFICID® (fidaxomicin) Tablets Launch
5. Optimer Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
6. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
7. Optimer Pharmaceuticals to Present at BioCentury Newsmakers Conference
8. Optimer Pharmaceuticals and Astellas Receive Positive Opinion from CHMP for European Approval of DIFICID™
9. Optimer to Provide DIFICID™ Launch Update at Morgan Stanley Global Healthcare Conference
10. Optimer Pharmaceuticals DIFICID Featured in 11 Presentations at 51st ICAAC
11. Optimer Pharmaceuticals to Present at September 2011 Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... NEW YORK , July 21, 2014  EHE ... physical exams with a nationwide physician network, today announced ... Las Vegas, NV has been named ... in the Las Vegas region ... to help proactively maintain their health. ...
(Date:7/21/2014)... July 21, 2014 ... Market Research "E-Clinical Solution Software Market- Global Industry Analysis, ... the global microfluidic device market was valued at USD ... at a CAGR of 13.8% from 2014 to 2020, ... in 2020. Browse the full E-Clinical Solution ...
(Date:7/21/2014)... LAS VEGAS , July 21, 2014 By ... Division will conduct an online sale of ophthalmic and optical ... Las Vegas -based eyewear specialists American Optical Services LLC. ... and will close in rapid succession, live auction style, ... the various assets being offered will be held July 25 ...
Breaking Medicine Technology:EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 4E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 5Auction Set For Assets Of National Optical Services Company 2
... , Aug. 2 /PRNewswire-Asia/ -- WuXi PharmaTech ... leading research and development outsourcing company serving the,pharmaceutical, biotechnology, ... the United States , today announced its financial results ... , (Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO ...
... ANNAPOLIS, Md. , July 30 PharmAthene, Inc. ... developing medical countermeasures against biological and chemical threats, today announced that ... the NYSE Amex LLC, stating that PharmAthene is not in compliance ... (iii) of the NYSE Amex Company Guide, because it has stockholders, ...
Cached Medicine Technology:WuXi PharmaTech Announces Second-Quarter 2010 Results 2WuXi PharmaTech Announces Second-Quarter 2010 Results 3WuXi PharmaTech Announces Second-Quarter 2010 Results 4WuXi PharmaTech Announces Second-Quarter 2010 Results 5WuXi PharmaTech Announces Second-Quarter 2010 Results 6WuXi PharmaTech Announces Second-Quarter 2010 Results 7WuXi PharmaTech Announces Second-Quarter 2010 Results 8WuXi PharmaTech Announces Second-Quarter 2010 Results 9WuXi PharmaTech Announces Second-Quarter 2010 Results 10WuXi PharmaTech Announces Second-Quarter 2010 Results 11WuXi PharmaTech Announces Second-Quarter 2010 Results 12WuXi PharmaTech Announces Second-Quarter 2010 Results 13WuXi PharmaTech Announces Second-Quarter 2010 Results 14WuXi PharmaTech Announces Second-Quarter 2010 Results 15WuXi PharmaTech Announces Second-Quarter 2010 Results 16PharmAthene Provides Update on NYSE Amex Listing Compliance Plan 2PharmAthene Provides Update on NYSE Amex Listing Compliance Plan 3
(Date:7/22/2014)... The hair transplant experts at ... robotic assisted laser therapy and robotic assisted hair ... and women suffering from hair loss. Alongside their ... Follicular Unit Extraction (FUE) procedures via ARTAS – ... new technology, their doctors use advanced digital mapping ...
(Date:7/21/2014)... target and kill cancer cells could boost the effectiveness ... avoid amputation, a new study reports. , Scientists at ... of a genetically engineered version of the virus used ... the virus alongside isolated limb perfusion chemotherapy given ... leg as an alternative to amputation was more ...
(Date:7/21/2014)... a well-known casket manufacturer from China, has recently added its ... In addition to this, the company is now giving great ... new items. , MillionaireCasket.com is a reliable supplier in ... its current and prospective clients. Its hot products include 18 ... According to the company’s sales manager, its website will be ...
(Date:7/21/2014)... 21, 2014 Cannabis Now Magazine recently ... events this summer. During these festivals, they will strengthen ... information and resources to attendees in an effort to ... on the legitimate and beneficial side of cannabis. , ... San Francisco, the Kush Expo in Anaheim, the Champs ...
(Date:7/21/2014)... losing. , Unfortunately, it,s also human nature to ... and thus increasing your chances of losing the next ... Young University study published this week by the journal ... an analysis of two decades of data on NBA ... adjusted their personnel following games where the margin of ...
Breaking Medicine News(10 mins):Health News:WeGrowHair.com/PAI Medical Group Introduces Robotic Assisted Laser Therapy to Treat Hair Loss 2Health News:Viral therapy could boost limb-saving cancer treatment 2Health News:Viral therapy could boost limb-saving cancer treatment 3Health News:Cheap Maple Caskets Recently Added To China Casket Manufacturer MillionaireCasket.com’s Product Line 2Health News:Cannabis Now Magazine Hits the Marijuana Festival Circuit and Sponsors Two Major Events 2Health News:'Moral victories' might spare you from losing again 2
... , , BURLINGTON, N.J., Aug. 5 ... Presbyopia which is the increased difficulty to focus on nearby objects. ... a current study performed at the Kajita Clinic in Tokyo, Japan ... ability to focus on nearby objects in older subjects (mean age ...
... , RESEARCH TRIANGLE PARK, N.C., ... to developing treatments to regulate the adrenergic system, announced today ... long-range plan to advance the treatment of adrenergic-related conditions throughout ... and sell its lead product, Clonicel, in Korea to Dream ...
... , ... Lexmark combine industry-leading RFID software, services with industry-first RFID laser printing capabilities to ... ... August 5, 2009 -- Today, FileTrail Inc, the leading provider of browser-based records management ...
... , , Got ... , ROSEMONT, Ill., Aug. 5 The ... for submissions to its fifth annual MORE Awards . ... and healthy behaviors in the care of bones, joints and muscles. ...
... , , , ... Health Solutions, Inc. (Nasdaq: STRM ) today announced that, ... the Company should have an independent, non-management director as the Company,s ... appointed Jonathan R. Phillips, a current independent member of the Company,s ...
... ... recognized immigration attorneys, offers on-site immigration law consultations, presentations, seminars and ... mandates. The current immigration climate places increased scrutiny on employers ... these challenges affect their business and what can be done to ...
Cached Medicine News:Health News:The Reduction of Eye Fatigue Improves Vision in Older Subjects 2Health News:Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma 2Health News:FileTrail Joins With Lexmark To Offer End-to-End RFID-Enabled Item Management, Tracking, and Printing Solutions 2Health News:FileTrail Joins With Lexmark To Offer End-to-End RFID-Enabled Item Management, Tracking, and Printing Solutions 3Health News:FileTrail Joins With Lexmark To Offer End-to-End RFID-Enabled Item Management, Tracking, and Printing Solutions 4Health News:MORE (Media Orthopaedic Reporting Excellence) Awards Call for Entries is Now Open 2Health News:MORE (Media Orthopaedic Reporting Excellence) Awards Call for Entries is Now Open 3Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 2Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 3Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 4Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 5Health News:Immigration Attorneys Make Immigration Law & Employment Visas Easier for Foreign Workers, U.S. Employers, Corporations and Corporate Counsel 2Health News:Immigration Attorneys Make Immigration Law & Employment Visas Easier for Foreign Workers, U.S. Employers, Corporations and Corporate Counsel 3Health News:Immigration Attorneys Make Immigration Law & Employment Visas Easier for Foreign Workers, U.S. Employers, Corporations and Corporate Counsel 4Health News:Immigration Attorneys Make Immigration Law & Employment Visas Easier for Foreign Workers, U.S. Employers, Corporations and Corporate Counsel 5
... Ellex Solitaire represents the latest in green ... system for use in both the operating ... surgeon preference testing and the most experienced ... Solitaire is the premium 532nm photocoagulator - ...
... Eyelid Implants feature a proprietary three-dimensional design ... ocular globe. The Contour Eyelid Implant ... eyelid because the tapered lower edge and ... Surfaces and edges of the implant are ...
... IOPac give you corrected IOP measurements in ... the importance of CCT. Make your IOP ... handheld glaucoma pachymeter with built-in IOP calculations. ... care professional, it provides accurate corneal measurements in ...
The TOPCON SP-2000P Non -Contact Specular Microscope is a new generation of diagnostic accuracy and versatility in non-contact specular microscopy. The SP-2000P can be linked to TOPCON's IMAGEnet sys...
Medicine Products: